We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for pemigatinib (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate release tablet
Indication
Treatment of cholangiocarcinoma (CCA)
Therapeutic area
Oncology